Business Context and Reporting Period
Company: HealthEquity, Inc. (HQY)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended April 30, 2026 (Fiscal Q1 2027)
Business Overview: HealthEquity is a leading administrator of Health Savings Accounts (HSAs) and complementary consumer-directed benefits (CDBs). As of April 30, 2026, the company administered 10.6 million HSAs with total assets of $37.1 billion and 7.2 million CDBs, totaling 17.8 million accounts.
Key Financial Metrics
| Metric (in thousands, except per share) | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $354,641 | $330,844 |
| Net Income | $69,418 | $53,915 |
| Diluted EPS | $0.82 | $0.61 |
| Adjusted EBITDA | $164,488 | $140,208 |
| Operating Cash Flow | $97,526 | $64,738 |
| Cash and Equivalents (Ending) | $265,369 | $287,894 |
| Long-Term Debt (Net) | $942,656 | $957,379 |
| Gross Margin | 72.3% | 67.8% |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 7% ($23.8 million) year-over-year. Custodial revenue drove the majority of growth, rising 11% ($17.9 million) due to higher average annualized yields on HSA cash (3.84% vs. 3.50%) and a one-time $2.4 million benefit from an early contract termination.
- Profitability: Net income increased 29% ($15.5 million). Gross profit expanded to $256.3 million (72.3% margin) from $224.3 million (67.8% margin), primarily due to a decrease in service costs (down 11%) driven by technology efficiencies and lower fraud reimbursement costs.
- Operating Expenses: Total operating expenses rose 9% ($12.1 million). General and administrative expenses increased 22% ($5.6 million), largely due to non-recurring stock-based compensation related to the retirement of the former CEO. Technology and development expenses increased 10% ($6.3 million) due to higher software costs.
- Capital Allocation: The company repurchased $123.3 million of common stock (1.5 million shares) during the quarter. In May 2026, the board authorized an additional $1.0 billion for repurchases.
Outlook, Risks, and Contingencies
- Guidance & Outlook: Management expects service revenue to continue increasing due to marketplace revenue and HSA investments. Custodial revenue is expected to rise as existing low-yield contracts expire and are replaced with higher-yield agreements. Interchange revenue is projected to grow with account volume, though average rates may decline.
- Legal Contingencies: The company is subject to a consolidated putative class action lawsuit regarding a fiscal 2025 cybersecurity incident involving a business partner's user account. The company filed a renewed motion to compel arbitration in May 2026. No loss accrual has been recorded as the outcome is not estimable, though an unfavorable result could materially impact financials.
- Regulatory Environment: The "One Big Beautiful Bill Act" signed in July 2025 expanded HSA eligibility, which management views as a growth driver. However, changes in tax law or healthcare policy (e.g., "Medicare for all") remain significant risks.
- Interest Rate Risk: Custodial revenue is sensitive to interest rates. The company uses Treasury bond forwards to hedge benchmark interest rate risk. A sustained decline in rates could reduce custodial revenue.
Investor Verification Checklist
- Stock Repurchase Authorization: Verify the impact of the new $1.0 billion repurchase authorization approved in May 2026 on future share count and liquidity.
- Custodial Yield Sustainability: Assess the durability of the 3.84% average annualized yield on HSA cash, noting the inclusion of a one-time $2.4 million benefit from contract termination.
- Legal Exposure: Monitor the status of the cybersecurity class action lawsuit and potential regulatory inquiries, as no provision has been made for potential losses.
- Debt Covenants: Confirm continued compliance with the Credit Agreement covenants (max 5.00x net leverage, min 3.00x interest coverage), especially given the $346.9 million outstanding on the revolving facility.
- Non-GAAP Reconciliations: Review the reconciliation of Adjusted EBITDA and Non-GAAP Net Income to understand the impact of excluding amortization of acquired intangibles and stock-based compensation.